Here is a fact. The convertible threw down the stock price like gravity but it raised $30 million plus to keep the company alive for over one year. Simpson HOPES to be able to discuss more freely end of phase 3 in the latter half of this year. If that HOPE materializes, then 2019 will see the end of phase 3.
120 patients to best alternative care, 120 patients to CS or maybe about 480 total CS treatments my guess if trial goes to full length. Maybe first 100 CS treatments to ICC phase 3. Maybe upwards of 700 commercial treatments in Europe. Rapture is the lead driver in modern times for too soon too far but how about enough of the bearish rinse and repeat mantra
Delcath legitimate, Simpson legitimate, disclaimer not in stock currently